What the company does
Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for adult patients with relapsed or refractory (R/R) diffuse large b-cell lymphoma (DLBCL), large B-cell lymphoma, and follicular lymphoma (FL); and Tivdak for adult patients with recurrent/metastatic cervical cancer with disease progression on or after chemotherapy. It is also developing Epcoritamab for R/R DLBCL and FL, first line DLBCL and FL, B-cell non-Hodgkin lymphoma, R/R chronic lymphocytic leukemia and Richter's syndrome, and aggressive mature B-cell neoplasms in pediatric …
What the weekly tape is saying
GMAB closed the latest completed week at 1,619 DKK. The 4-week return is -3.9% and the 12-week return is -1.1%. Trend Signal is inactive, Market Dynamics is -0.09. Setup signature: Risk-first tape with a 33/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,860 DKK
- Vs Trend Line
- -12.9%
- Fair Value
- 1,854 DKK
- Vs Fair Value
- -12.7%
- 52W High
- 2,257 DKK
- 52W Low
- 1,275 DKK
- Drawdown
- -28.3%
- Range Position
- 35.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 26
- 52W Active Breadth
- 50.0%
- Sector Scope
- DK Healthcare
- Sector Rank
- 3 of 21
- Sector Percentile
- 90.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
DK Healthcare
- Tracked Peers
- 21
- 4W Rank
- 14 of 21
- Avg 1W
- -0.6%
- Avg 4W
- 1.9%
- Trend Breadth
- 28.6%
- Positive MD
- 66.7%
DK Biotechnology
- Tracked Peers
- 7
- 4W Rank
- 4 of 7
- Avg 1W
- -0.5%
- Avg 4W
- -2.1%
- Trend Breadth
- 14.3%
- Positive RS
- 14.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.09
- 4W MD Change
- 92.6%
- Relative Strength
- -10.37
- 4W RS Change
- -85.5%
- Expectation
- Undecided
- Probability
- 51.67%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 641.2K
- 13W Average
- 679.8K
- 52W Average
- 649.5K
- Vs 13W
- 0.9x
- Vs 52W
- 1.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.4%
- 52W Volatility
- 4.7%
- Upside Weeks
- 27
- Downside Weeks
- 25
- Downside Breadth
- 48.1%
- Avg Gain / Loss
- 3.8% / -3.5%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- CPH
- Country
- DK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- DKK
- Market Cap
- 100.6B
Opportunity signals
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,619 DKK | 2.2% | 1,860 DKK | 1,854 DKK | -0.09 | -10.37 | 641.2K | Off |
| 5 Jun 2026 | 1,584 DKK | -7.1% | 1,871 DKK | 1,861 DKK | -0.28 | -11.44 | 827.2K | Off |
| 29 May 2026 | 1,704 DKK | -1.1% | 1,880 DKK | 1,868 DKK | -0.46 | -6.04 | 1.1M | Off |
| 22 May 2026 | 1,724 DKK | 2.3% | 1,884 DKK | 1,874 DKK | -0.88 | -4.71 | 846.3K | Off |
| 15 May 2026 | 1,684 DKK | 2.6% | 1,890 DKK | 1,881 DKK | -1.19 | -5.59 | 532.9K | Off |
| 8 May 2026 | 1,642 DKK | -3.1% | 1,904 DKK | 1,888 DKK | -1.23 | -6.41 | 1.1M | Off |
| 1 May 2026 | 1,694 DKK | -1.0% | 1,917 DKK | 1,896 DKK | -1.23 | -3.53 | 480.6K | Off |
| 24 Apr 2026 | 1,711 DKK | -5.2% | 1,931 DKK | 1,903 DKK | -1.24 | -1.21 | 579.4K | Off |
| 17 Apr 2026 | 1,804 DKK | 0.8% | 1,935 DKK | 1,910 DKK | -1.27 | 1.33 | 593.9K | Off |
| 10 Apr 2026 | 1,790 DKK | 1.8% | 1,935 DKK | 1,916 DKK | -1.33 | 2.69 | 566.0K | Off |
| 3 Apr 2026 | 1,758 DKK | 4.5% | 1,936 DKK | 1,923 DKK | -1.42 | 3.99 | 293.3K | Off |
| 27 Mar 2026 | 1,682 DKK | 2.8% | 1,935 DKK | 1,928 DKK | -1.33 | 4.27 | 561.9K | Off |
| 20 Mar 2026 | 1,637 DKK | -3.8% | 1,932 DKK | 1,934 DKK | -1.25 | 2.80 | 694.7K | Off |
| 13 Mar 2026 | 1,702 DKK | -1.5% | 1,930 DKK | 1,940 DKK | -1.20 | 4.53 | 639.4K | Off |